Endogenous Hormone Levels, Mammographic Density, and Subsequent Risk of Breast Cancer in Postmenopausal Women
Open Access
- 24 July 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 99 (15), 1178-1187
- https://doi.org/10.1093/jnci/djm062
Abstract
Mammographic density and circulating sex hormones are two well-confirmed predictors of breast cancer risk. Whether mammographic density reflects levels of endogenous sex hormones is unclear. We examined whether these predictors are independently associated with breast cancer risk in a prospective study. We conducted a nested case–control study within the Nurses’ Health Study cohort of 253 case subjects with breast cancer and 520 control subjects. All participants were postmenopausal women who were not using postmenopausal hormones at the time of both blood collection and mammography. Plasma levels of estradiol, free estradiol, testosterone, and free testosterone were evaluated. Mammographic density was assessed by use of computer-assisted analysis of mammograms. Logistic regression models that were adjusted for matching variables and potential confounders were used to calculate relative risks (RRs) and 95% confidence intervals (CIs). All statistical tests were two-sided. Levels of circulating sex steroids and mammographic density were both statistically significantly and independently associated with breast cancer risk. The relative risk of breast cancer associated with mammographic density (RR for highest quartile compared with lowest quartile = 3.8, 95% CI = 2.2 to 6.6; Ptrend <.001) changed little when the analysis was adjusted for circulating estradiol (RR = 3.9, 95% CI = 2.2 to 6.9; Ptrend <.001) or circulating testosterone (RR = 4.1, 95% CI = 2.3 to 7.2; Ptrend <.001). Circulating levels of estradiol (RR = 2.4, 95% CI = 1.4 to 4.0) and of testosterone (RR = 2.0, 95% CI = 1.2 to 3.1) were both associated with breast cancer risk, before and after adjustment for mammographic density. In a joint analysis of mammographic density and plasma testosterone, the risk of breast cancer was highest in the highest tertiles of both relative to the lowest tertiles of both (RR = 6.0, 95% CI = 2.6 to 14.0). A similar pattern was observed in the joint analysis of estradiol and mammographic density (RR = 4.1, 95% CI = 1.7 to 9.8). Circulating sex steroid levels and mammographic density appear strongly and independently associated with the risk of breast cancer in postmenopausal women.This publication has 54 references indexed in Scilit:
- Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal WomenJNCI Journal of the National Cancer Institute, 2006
- Mammographic Breast Density and the Gail Model for Breast Cancer Risk Prediction in a Screening PopulationBreast Cancer Research and Treatment, 2005
- Estrogen-Plus-Progestin Use and Mammographic Density in Postmenopausal Women: Women's Health Initiative Randomized TrialJNCI Journal of the National Cancer Institute, 2005
- The Association of Endogenous Sex Steroids and Sex Steroid Binding Proteins with Mammographic Density: Results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density StudyAmerican Journal of Epidemiology, 2005
- The local hormonal environment and related biomarkers in the normal breastEndocrine-Related Cancer, 2005
- The GH–IGF-I axis and breast cancerTrends in Endocrinology & Metabolism, 2003
- Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal womenEuropean Journal of Cancer and Clinical Oncology, 1986
- Percentage Points for a Generalized ESD Many-Outlier ProcedureTechnometrics, 1983
- Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperatureJournal of Steroid Biochemistry, 1982
- Chromatographic purification of estradiol-17β for use in radio-ligand assayBiochemical Medicine, 1970